Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 4/20 | 0.33 |
| ▸ | ADH1C | P00326 | 3/20 | 0.33 |
| ▸ | ADH4 | P08319 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13508246 | 0.84 | ADH1A (0.50) | ADH1AADH1CADH4 | |
| SCHEMBL1276729 | 0.84 | ADH1A (0.50) | ADH1AADH1CADH4 | |
| SCHEMBL4096853 | 0.81 | ADH1A (0.51) | ADH1AADH1CADH4 | |
| SCHEMBL4099343 | 0.80 | ADH1A (0.58) | ADH1AADH1CADH4 | |
| SCHEMBL3836879 | 0.79 | ADH1A (0.61) | ADH1AADH1CADH4 | |
| SCHEMBL4096213 | 0.79 | ADH1A (0.61) | ADH1AADH1CADH4 | |
| SCHEMBL4093337 | 0.79 | ADH1A (0.61) | ADH1AADH1CADH4 | |
| SCHEMBL14142422 | 0.75 | CNR2 (0.33) | ADH1AADH1C | |
| SCHEMBL5820476 | 0.70 | ADH1C (0.33) | ADH1AADH1CADH4 | |
| SCHEMBL4106046 | 0.70 | ADH1A (0.57) | ADH1AADH1CADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8277695-B2 | Reversibly thermochromic compositions | BASF SE (DE) | 2012-10-02 | — | — | US | disclosed |
| US-8119778-B2 | Reversibly thermochromic compositions | BASF SE (DE) | 2012-02-21 | — | — | US | disclosed |
| US-20110180767-A1 | Reversibly thermochromic compositions | CIBA CORPORATION | 2011-07-28 | — | — | US | disclosed |
| US-20110092632-A1 | POROUS INORGANIC MATERIALS CONTAINING POLYMER ADDITIVES | BRAND FABIEN JEAN | 2011-04-21 | — | — | US | disclosed |
| US-7820744-B2 | Stabilizer mixtures | CIBA SPECIALTY CHEMICALS CORP. (US) | 2010-10-26 | — | — | US | disclosed |
| US-20100234494-A1 | Reversibly thermochromic compositions | CIBA CORPORATION | 2010-09-16 | — | — | US | disclosed |
| US-7687554-B2 | Water based concentrated product forms of light stabilizers made by a heterophase polymerization technique | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-03-30 | — | — | US | disclosed |
| US-20100048774-A1 | STABILIZER MIXTURES | GUGUMUS FRANCOIS | 2010-02-25 | — | — | US | disclosed |
| US-20100048773-A1 | AGRICULTURAL ARTICLES | BONORA MICHELA | 2010-02-25 | — | — | US | disclosed |
| US-7628936-B2 | Mixture of steric hindred amine compound with magnesium and zinc salt; photostability; heat and oxidation resistance; for polymers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2009-12-08 | — | — | US | disclosed |
| US-7595008-B2 | Mixture containing steric hindred amine compound with zinc and magnesium salt; photostability; heat and oxidation resistance; for polymers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2009-09-29 | — | — | US | disclosed |
| US-20090111917-A1 | Stabilized articles | BONORA MICHELA | 2009-04-30 | — | — | US | disclosed |
| US-20090105379-A1 | Stabilizer mixtures | GUGUMUS FRANCOIS | 2009-04-23 | — | — | US | disclosed |
| US-20090093572-A1 | Stabilizer mixtures | GUGUMUS FRANCOIS | 2009-04-09 | — | — | US | disclosed |
| US-20080058459-A1 | Porous Inorganic Materials Containing Polymer Additives | CIBA CORP. | 2008-03-06 | — | — | US | disclosed |
| US-20070135537-A1 | Agricultural articles | BONORA MICHAEL | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234494-A1 | Reversibly thermochromic compositions | CRY1, REL, CRY2 | ADH1A 2329/4885ADH1C 2012/4885ADH4 2656/4885 |
| US-20110180767-A1 | Reversibly thermochromic compositions | C1R, C3AR1, C9 | ADH1A 1787/4885ADH1C 1704/4885ADH4 4019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.